跳至主要内容
临床试验/NCT03116191
NCT03116191已完成2 期

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Sanwa Kagaku Kenkyusho Co., Ltd.1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2017年2月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
125
试验地点
1
主要终点
Change from baseline in mean number of nocturnal voids

研究概览

简要总结

The purpose of this trial is to demonstrate efficacy of SK-1404 against placebo for the treatment of subjects with nocturia due to nocturnal polyuria, during 4 weeks of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
55 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 5 > nocturnal voids ≥2
  • NPI >0.33

排除标准

  • Polydipsia
  • Cardiac failure
  • Syndrome of inappropriate antidiuretic hormone secretion
  • Hyponatraemia
  • Uncontrolled diabetes mellitus
  • Uncontrolled hypertension
  • Moderate or severe over-active bladder (OAB)
  • Severe benign prostate hyperplasia (BPH)
  • Sleep apnoea
  • Interstitial cystitis
  • Stress urinary incontinence
  • Diabetes insipidus
  • Complication or a history of urological cancer

研究组 & 干预措施

SK-1404 low dose

Experimental

干预措施: SK-1404 (Drug)

SK-1404 high dose

Experimental

干预措施: SK-1404 (Drug)

SK-1404 middle dose

Experimental

干预措施: SK-1404 (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Change from baseline in mean number of nocturnal voids

时间窗: 4 weeks

Assessed by the voiding diary

次要结局

  • Change from base line in mean time to first awakening to void(4 weeks)
  • Change from base line in the score of Nocturia-Specific Quality-of-Life Questionnaire (N-QoL)(4 weeks)
  • Change from base line in mean nocturnal urine volume(4 weeks)
  • Change from base line in mean Nocturnal Polyuria Index (NPI)(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Trial of SK-1404 for Nocturia Due to Nocturnal... | 临床试验